PASITHEA THERAPEUTICS CORP. Deferred Tax Assets, Other
PASITHEA THERAPEUTICS CORP. (KTTA) had Deferred Tax Assets, Other of $0 as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2026-08-14
- 2026-06-30: Deferred Tax Assets, Other $0.00.
- 2025-12-31: Deferred Tax Assets, Other $0.00.
- 2025-09-30: Deferred Tax Assets, Other $0.00.
- 2025-06-30: Deferred Tax Assets, Other $0.00.
| Period end | Deferred Tax Assets, Other |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2021-12-31 | $11.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |